Europe Transdermal Drug Delivery System Market is expected to reach US$ 2,060.00 Mn by 2027

Transdermal Patch Segment to Witness Higher CAGR During Forecast Period

According to the latest study on “Europe Transdermal Drug Delivery System Market Forecast to 2027 – COVID-19 Impact and Analysis – by Type, Application, and End User,” the market was valued at US$ 1,524.63 million in 2019 and is projected to reach US$ 2,060.00 million by 2027; it is expected to grow at a CAGR of 4.0% during 2020–2027. The report highlights trends prevailing in the Europe transdermal drug delivery system market and the factors driving market along with those that act as hindrances.

Based on type, the Europe transdermal drug delivery system market is segmented into transdermal patch and transdermal semisolids. The transdermal patch segment is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches and micro needle patches. The transdermal semisolids segment is further sub segmented into gels, ointments and sprays. In 2019, the transdermal patch segment held a larger share of the market. Also, it is expected to grow at a faster rate during the forecast period.

The growth of the Europe transdermal drug delivery system market is attributed to the increasing prevalence of chronic diseases, growing demand for non-invasive drug delivery devices, and high demand for self-administration of drugs. However, drug failure and recalls of transdermal drug delivery systems limits the growth of market in this region.

GlaxoSmithKline plc, Novartis AG, Boehringer Ingelheim International GmbH, Lavipharm, and Bayer AG are among the leading companies operating in the Europe transdermal drug delivery system market.

Europe Transdermal Drug Delivery System Market, By Country, 2019 (%) 

The report segments Europe transdermal drug delivery system market as follows:

By Type

• Transdermal Patches
  • Matrix Patches
  • Microneedle Patches
  • Drug-In-Adhesive Patches
  • Reservoir Membrane Patches
• Transdermal Semisolids
  • Sprays
  • Gels
  • Ointments

By Application

• Cardiovascular Diseases
• Central Nervous System Disorders
• Pain Management
• Hormonal Applications
  • Transdermal Estrogen Therapy
  • Testosterone Replacement Therapy
• Other Applications

By End User

• Hospitals and Clinics
• Home Care Settings
• Other End Users

By Country

• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe